menu
    • menu

    Company profile for Hetero Biopharma

    NEW Drugs in Dev: 3
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    As a part of the Hetero Group, our Biologics vertical, comes with a rich legacy - Proven capabilities in the development, manufacturing and marketing of chemical intermediates, APIs, ARVs and Finished Dosage Formulations. With leadership in chemical therapeutics, Hetero continues to lead from the front in the development and manufacturing of Biopharmaceuticals using novel technologies. Hetero has 36 state-of-the-art manufa...
    As a part of the Hetero Group, our Biologics vertical, comes with a rich legacy - Proven capabilities in the development, manufacturing and marketing of chemical intermediates, APIs, ARVs and Finished Dosage Formulations. With leadership in chemical therapeutics, Hetero continues to lead from the front in the development and manufacturing of Biopharmaceuticals using novel technologies. Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide. And a majority of our facilities have been successfully audited and approved by stringent regulatory authorities like US FDA, EU, TGA-Australia, MCC-South Africa

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hetero Biopharmaindia-flag Flag
    Country
    Country
    India
    Address
    Address
    #8-3-166/1 & 2, 105 to 108, 1st Floor, G Block, East Wing, Challa Estates, Err...
    Telephone
    Telephone
    +91 40 23704923
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.heterobiopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/BiopharmaHetero

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hetero’s Generics Promethazine HCl Receives Approval in US
    Hetero’s Generics Promethazine HCl Receives Approval in US

    12 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218264

    FDA
    12 Mar 2026
    Share Share
    MS Pharma Group Inks Exclusive Biosimilars Deal With Hetero
    MS Pharma Group Inks Exclusive Biosimilars Deal With Hetero

    26 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ms-pharma-group-signs-exclusive-biosimilars-partnership-agreement-with-hetero-302670078.html

    PR NEWSWIRE
    26 Jan 2026
    Share Share
    Dr. Reddy's, Hetero Secure Support to Produce Generic Yeztugo
    Dr. Reddy's, Hetero Secure Support to Produce Generic Yeztugo

    24 Sep 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/indian-generic-makers-poised-sell-40-versions-gileads-hiv-prep-yeztugo-through-deals-gates

    FIERCE PHARMA
    24 Sep 2025
    Share Share
    Johnson & Johnson sells its largest India plant as demand weakens
    Johnson & Johnson sells its largest India plant as demand weakens

    18 Oct 2022

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/johnson-johnson-sells-its-largest-india-plant-as-demand-weakens/articleshow/94926683.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMICTIMES
    18 Oct 2022
    Share Share
    Hetero acquires Johnson & Johnson's manufacturing plant in Telangana
    Hetero acquires Johnson & Johnson's manufacturing plant in Telangana

    17 Oct 2022

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hetero-acquires-johnson-johnsons-manufacturing-plant-in-telangana/articleshow/94914520.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMICTIMES
    17 Oct 2022
    Share Share
    Hetero Biopharma asked to submit more data on Sputnik Light
    Hetero Biopharma asked to submit more data on Sputnik Light

    16 Feb 2022

    // Teena Thacker ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/hetero-asked-to-submit-more-data-on-sputnik-light/articleshow/89600216.cms

    Teena Thacker ECONOMIC TIMES
    16 Feb 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search